Join experts Carlos Aguiar, a cardiology specialist, Christiaan Vrints from Antwerp University Hospital, and Marco Witkowski of Charité University, as they unpack critical insights on angina management. They discuss the latest ESC guidelines for chronic coronary syndromes and the importance of personalized treatment strategies. The conversation also delves into the cardiovascular risks associated with artificial sweeteners like erythritol, emphasizing the need for caution in using these alternatives, especially in vulnerable populations.

Join leading cardiology experts Carlos Aguiar and Milind Desai, alongside the witty Rohin Francis, as they delve into the latest advancements in drug treatments for hypertrophic cardiomyopathy. They discuss innovative therapies, including cardiac myosin inhibitors, and evaluate their efficacy and safety. The trio also highlights the healing power of humor in medicine, sharing how laughter can enhance patient communication and reduce anxiety. Plus, dive into the fundamentals of regression analysis in medical research for a comprehensive and entertaining experience!

Leading experts Stephan Achenbach, Carlos Aguiar, Emma Svennberg, David Capodanno, and Nicolle Kraenkel discuss the latest developments in cardiovascular medicine, including new pharmacologic approaches for hypertrophic obstructive cardiomyopathy and advancements in intravascular imaging in coronary interventions. They also highlight the Atesia trial, which compares oral anticoagulant therapy for subclinical atrial fibrillation and discuss the top cardiology papers of 2023, including a study on the blood pressure-lowering effects of tomatoes.

Cardiologist Carlos Aguiar, spirituality expert Kavitha Chinnaiyan, and renowned cardiologist Francesco Maisano discuss lifetime management of aortic valve stenosis and the impact of spirituality on cardiovascular health. Topics include personalized therapy options, integrating spirituality in patient care, and the use of AI technology for statistical analyses in medicine.

Cardiology experts Carlos Aguiar and Deepak Bhatt discuss omega-3 fatty acids benefits and lead-induced tricuspid regurgitation. They explore TAVI outcomes, heart failure, genetic predispositions, and the impact of EPA on cardiovascular health. Martin Andreas provides insights on tricuspid regurgitation in patients with implanted leads. Mythbusters segment examines the effects of pomegranates on heart health.

In this engaging discussion, guests Carlos Aguiar, a leading cardiology expert, Sana Al-Khatib from Duke University, and Rudolf de Boer from Erasmus University dive into the intricacies of heart failure treatment. They clarify which mineralocorticoid receptor antagonists (MRAs) suit different heart failure patients. Sana tackles the complex management of electrical storms, while Rudolf sheds light on the use of aldosterone antagonists. The group also debunks myths, like garlic's role in heart health, ensuring listeners stay well-informed on vital cardiovascular topics.

Join experts Stephan Achenbach, a leading cardiology figure, Carlos Aguiar, lipid management authority, Kyle Klarich, cardiac specialist, and Konstantinos Koskinas, renowned researcher, as they dive into innovative strategies for managing cardiac fibroelastomas and advancing lipid therapy beyond statins. They discuss the latest research highlighting new therapeutic options, evaluate the effectiveness and side effects of current treatments, and examine the importance of LDL cholesterol reduction in cardiovascular health. A must-listen for those in the field!

Cardiologists Stephan Achenbach, Carlos Aguiar, Michael Boehm, and Lene Holmvang discuss topics like long-term beta blockers post-MI, pros and cons of microaxial pump in cardiogenic shock, patient selection for micro-axial pump, and benign cardiac imaging findings in an informative and engaging manner.

Experts in cardiology discuss immune checkpoint inhibitors and their impacts on the heart, the importance of HDL and its therapies for cardiovascular health, and the FBI syndrome. Topics include cardiovascular complications of immune checkpoint inhibitors, strategies to elevate HDL levels, and enhancing HDL carriers. The podcast also covers recent key studies in cardiology.

Stephan Achenbach, a leading cardiology expert, joins Carlos Aguiar, a top atrial fibrillation researcher, Jane Armitage, a clinician renowned for her work on clinical trials, and Isabel Deisenhofer, an authority on cardiovascular study evaluation. They dive into strategic decisions in managing atrial fibrillation, discussing new guidelines that emphasize rhythm control and catheter ablation. The group also explores the importance of designing reliable clinical trials and the need for patient involvement in advanced cardiac treatment decisions.